A Phase I, Open-Label Study Evaluating the Pharmacokinetics of Components of S-1 in Patients With Varying Degrees of Renal Function
Phase of Trial: Phase I
Latest Information Update: 11 Jun 2014
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Taiho Pharmaceutical
- 08 Apr 2011 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 08 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Mar 2011 Planned end date changed from 1 Apr 2010 to 1 Sep 2010 as reported by ClinicalTrials.gov.